Ophthalmology Research and Drug Development | Charles River

ophthalmology 

 
 

With the expected changes in demographics over the next 10-15 years, there is a growing need to increase and accelerate the development of safe and effective therapies for eye disorders. Charles River has the necessary understanding of eye-related diseases and conditions as well as the technical ability and experience to guide your new drugs and treatments through the development process as efficiently as possible. 

Through our Research Models and Preclinical Services groups, we offer you an integrated approach to ophthalmology research. Compounds or implantable devices intended for ocular treatment can be assessed for efficacy, safety and toxicity. In addition, ocular effects of compounds targeted to non-ocular conditions can also be characterized.

  • Research models
  • Specialty models (list not all-inclusive)
    • Choroidal neovascularization (CNV) models
    • Streptozotocin (STZ)-induced diabetic retinopathy
    • Retinal degeneration
    • Intraocular lens (IOL)
    • Corneal pouch
    • Corneal epithelial wound healing
    • Gland removal for dry eye model
  • Multiple species and dosing routes
  • Safety assessment
  • Board-certified veterinary ophthalmologists
  • Pathology
  • Phototoxicology
  • Tissue/organ imaging and photography
  • Drug metabolism and pharmacokinetics
Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
Mar 02 - BioPharm International: Meeting Ch...
Feb 13 - Fourth-Quarter and Full-Year 2011 ...
Jun 02-Jun 05 - Vancouver, British Columbia - CALAS
Jun 05-Jun 08 - Saint Germain sur l’Arbresle, France - Charles River LAL Seminar Series
view all
Manager International Tax Wilmington, MA
Scientist I Wilmington, MA

Charles River Laboratories, Inc.